Details

Category:

Other publications

Type:

Other publications

Title of issue:

Journal of Geriatric Care and Research. 2016, Vol 3, No 2

Publication year:

2016

Bibliography: test

1. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993; 129:92-6. open in new tab
2. Devi K, George S, Criton S, Suja V, Sridevi PK. Carbamazepine --the commonest cause of toxic epidermal necrolysis and Stevens-Johnson syndrome: A study of 7 years. Indian J Dermatol Venereol Leprol 2005; 71:325-8. open in new tab
3. Roujeau JC, Stern RS. Severe Adverse Cutaneous Reactions to drugs. N Engl J Med 1994; 331:1272-85. open in new tab
4. Tennis P, Stern RS. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study. Neurology 1997; 49:542- 6. open in new tab
5. Frisch PO, Ruiz-Maldonado R. Erythema multiforme, Stevens Johnson syndrome and toxic epidermal necrolysis. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, editors. Fitzpatrick's dermatology in general medicine, 6th edn. New York: McGraw-Hill; 2003. p. 543-57.
6. Roujeau JC, Guillaume JC, Fabre JP, Penso D, Flechet ML, Girre JP. Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981-1985. Arch Dermatol 1990; 126:37-42. open in new tab
7. Chan HL, Stern RS, Arndt KA, Langlois J, Jick SS, Jick H, et al. The incidence of erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis. Arch Dermatol 1990; 126:43-7. open in new tab
8. Kamaliah MD, Zainal D, Moktar N, Nazmi N. Erythema multiforme, Stevens Johnson syndrome and toxic epidermal necrolysis in north eastern Malaysia. Int J Dermatol 1998; 37:520-3. open in new tab
9. Rzany B, Correia O, Kelly JP, Naldi L, Auquier A, Stern R. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions. Lancet 1999; 353:2190-4. open in new tab
10. Sharma VK, Vatve M, Sawhney IM, Kumar B. Clinical spectrum of drug rashes due to antiepileptics. J. Assoc. Physicians India 1998;46:595-597. open in new tab
11. Varghese ST, Balhara YP, Shyamsunder S et al. Dermatological side effects of olanzapine. Indian J Med Sci 2005; 59: 320-321. open in new tab
12. Luciana Porto Cavalcante da N, Leonardo B, Fabiane K et al. Drug eruptions associated with ziprasidone. Rev Psiquiatr Clín 2005; 32 : 84-7.
13. Desarkar P, Nizamie SH. Risperidone-induced erythema multiforme minor. British Journal of Clinical Pharmacology 2006; 62(4): 504-505. open in new tab
14. Letko E, Papaliodis DN, Papaliodis GN, Daoud YJ. Ahmed AR, Foster CS. Stevens-Johnson syndrome and Toxic epidermal necrolysis: A review of the literature. Ann Allergy Asthma Immunol 2005; 94:419-436. open in new tab
15. Billimoria FE, Shah PP. Drug reactions. In: Valia RG, Valia AR, editors. IADVL textbook of dermatology, 2nd edn. Mumbai: Bhalani Publishing House; 2001. p. 1280-312.
16. Kaur S, Nanda A, Sharma VK. Elucidation and management of 30 patients of drug induced toxic epidermal necrolysis [DTEN].
17. Indian J Dermatol Venereol Leprol 1990;56:196-9. open in new tab
18. Mockenhoupt M. Severe cutaneous adverse drug reactions, clinical features and epidemiology. [Schwere Arzneimittelreaktionen der Haunt]. open in new tab
19. German J Der Hautarzt 2005; 56(1): 24-31. open in new tab
20. Patel PP, Gandhi AM, Desai CK, Desai MK, Dikshit RK. An analysis of drug induced Stevens-Johnson syndrome; Indian J Med Res 2012; 136(6): 1051-3.
21. Sanmarkan AD, Sori T, Thappa DM, Jaisankar TJ. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis over a period of 10 years. Indian J Dermatol. 2011; 56:25-9.

show (21) hide

Verified by:

No verification